Scarica l'app Stockscreener
2.20
8.64%
0.175
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRVI Giù?
Forum
Previsione
Precedente Chiudi:
$2.025
Aprire:
$2.06
Volume 24 ore:
1.58M
Relative Volume:
0.89
Capitalizzazione di mercato:
$316.75M
Reddito:
$288.95M
Utile/perdita netta:
$-119.03M
Rapporto P/E:
-2.4431
EPS:
-0.9005
Flusso di cassa netto:
$60.67M
1 W Prestazione:
-0.90%
1M Prestazione:
-20.29%
6M Prestazione:
-51.97%
1 anno Prestazione:
-74.04%
Intervallo 1D:
$2.025
$2.21
Intervallo di 1 settimana:
$1.99
$2.40
Portata 52W:
$1.665
$9.95
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Nome
Maravai Lifesciences Holdings Inc
Settore
Industria
Telefono
(858) 546-0004
Indirizzo
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Confronta MRVI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
2.20 | 292.99M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | Iniziato | Guggenheim | Neutral |
| 2024-12-05 | Downgrade | Goldman | Neutral → Sell |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-08 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-08-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | Iniziato | Craig Hallum | Buy |
| 2023-12-12 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-08-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | Downgrade | Goldman | Buy → Neutral |
| 2023-01-05 | Downgrade | UBS | Buy → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-11-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2020-12-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Iniziato | BofA Securities | Buy |
| 2020-12-15 | Iniziato | Credit Suisse | Outperform |
| 2020-12-15 | Iniziato | Goldman | Buy |
| 2020-12-15 | Iniziato | Jefferies | Buy |
| 2020-12-15 | Iniziato | Robert W. Baird | Outperform |
| 2020-12-15 | Iniziato | Stifel | Buy |
| 2020-12-15 | Iniziato | William Blair | Outperform |
| 2020-12-14 | Iniziato | UBS | Buy |
Mostra tutto
Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Not Doing Enough For Some Investors As Its Shares Slump 27% - simplywall.st
Sentiment analysis tools applied to Maravai LifeSciences Holdings Inc.Insider Strategy for High Conviction Picks - Newser
Stock Traders Buy Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - Defense World
When is Maravai LifeSciences Holdings Inc. stock expected to show significant growthMaximize returns with strategic stock selection - Jammu Links News
How many analysts rate Maravai LifeSciences Holdings Inc. as a “Buy”Discover stocks with massive upside potential - Jammu Links News
Why is Maravai LifeSciences Holdings Inc. stock attracting strong analyst attentionHigh-yield market plays - Jammu Links News
Is Maravai LifeSciences Holdings Inc. stock overvalued or undervaluedBuild wealth steadily with smart trading - Jammu Links News
Does Maravai LifeSciences Holdings Inc. stock perform well during market downturnsFree Trend-Following Techniques - Jammu Links News
How does Maravai LifeSciences Holdings Inc. compare to its industry peersSkyrocketing profit margins - Jammu Links News
What are the latest earnings results for Maravai LifeSciences Holdings Inc.Outstanding investment returns - Jammu Links News
Is Maravai LifeSciences Holdings Inc. a growth stock or a value stockCapitalize on fast-moving market trends - Jammu Links News
Has Maravai LifeSciences Holdings Inc. found a price floorWatchlist Generator With Real-Time Entry - Newser
Pattern recognition hints at Maravai LifeSciences Holdings Inc. upsideFree Beginner Friendly Stock Selection Guide - Newser
Is Maravai LifeSciences Holdings Inc. meeting your algorithmic filter criteriaFree Swing Trading Entry Point Signals - Newser
Wells Fargo Reiterates a Buy Rating on Maravai LifeSciences Holdings (MRVI) - Insider Monkey
14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey
Price momentum metrics for Maravai LifeSciences Holdings Inc. explainedFree Capital Protection Trading Strategies - Newser
Why Maravai LifeSciences Holdings Inc. stock attracts strong analyst attention - metal.it
Published on: 2025-07-28 23:24:21 - metal.it
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025 - GlobeNewswire
Maravai LifeSciences to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 11 - Quiver Quantitative
Should I hold or sell Maravai LifeSciences Holdings Inc. stock in 2025Breakthrough capital growth - Jammu Links News
What are the technical indicators suggesting about Maravai LifeSciences Holdings Inc.Get real-time updates on market trends - jammulinksnews.com
What is the risk reward ratio of investing in Maravai LifeSciences Holdings Inc. stockConsistent triple-digit returns - Jammu Links News
What is the dividend policy of Maravai LifeSciences Holdings Inc. stockDiscover top stock picks for aggressive growth - Jammu Links News
What drives Maravai LifeSciences Holdings Inc. stock pricePowerful market insights - PrintWeekIndia
Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc.MRVI - FinancialContent
What analysts say about Maravai LifeSciences Holdings Inc. stockGame-changing returns - PrintWeekIndia
Is Maravai LifeSciences Holdings Inc. a good long term investmentTremendous portfolio expansion - PrintWeekIndia
Is Maravai LifeSciences Holdings Inc. stock overhyped or has real potentialRapid market gains - Jammu Links News
What institutions are buying Maravai LifeSciences Holdings Inc. stock nowFree Trend-Following Techniques - jammulinksnews.com
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc.MRVI - Business Wire
Maravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI) - Defense World
Maravai LifeSciences Holdings Inc. Stock Analysis and ForecastMarket-leading growth rates - Jammu Links News
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Maravai Lifesciences Holdings Inc Azioni (MRVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.24%
3.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):